Workflow
GEMO金茉瑞士抗衰美容仪
icon
Search documents
GEMO金茉与瑞士LaClinic Montreux开创细胞级抗衰新时代
Zheng Quan Ri Bao Wang· 2025-03-26 13:50
Core Viewpoint - GEMO Jinmo and LaClinic Montreux are collaborating to innovate in the field of cellular anti-aging technology, marking a significant advancement in high-end home beauty devices [1][5][17] Company Overview - GEMO Jinmo is recognized as a leading brand in the Swiss high-end anti-aging home beauty device market, partnering with LaClinic Montreux to enhance its product offerings [5][11] - LaClinic Montreux, founded by Dr. Michel E. Pfulg, is renowned for its personalized anti-aging treatments and is considered a benchmark in the global anti-aging field [11][13] Market Insights - The global anti-aging beauty market surpassed $60 billion in 2022, with a projected annual growth rate of 9.5% until 2030 [7] - In China, the anti-aging beauty device market exceeded 10 billion yuan in 2022, with expectations of over 20% annual growth in the next five years [7] Product Innovation - GEMO Jinmo has developed innovative products such as the GEMO Jinmo Collagen Machine, which integrates advanced technologies for effective cellular anti-aging [8][14] - The collaboration emphasizes a philosophy of "technology + experience + aesthetics," aiming to redefine cellular anti-aging technology in various scenarios [5][10] Strategic Collaboration - The partnership between GEMO Jinmo and LaClinic Montreux aims to create the world's first integrated medical and wellness care space, enhancing the customer experience [5][10] - Dr. Pfulg's visit to GEMO Jinmo's R&D center signifies a deepening of their strategic collaboration, reinforcing their commitment to advancing anti-aging technologies [1][17] Consumer Trends - There is a growing consumer demand for home beauty devices that are non-invasive, safe, and effective, leading to a shift towards high-end, professional-grade products [7][10] - GEMO Jinmo's focus on long-lasting, natural beauty aligns with changing consumer preferences in the anti-aging market [10][13]